Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Human Molecular Genetics
|
December 3, 2003
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase
Joanna L Jankowsky, Daniel J Fadale, Jeffrey Anderson, et al.
Autism Research : Official Journal of the International Society for Autism Research
|
February 26, 2013
Longitudinal Heschl's gyrus growth during childhood and adolescence in typical development and autism
Molly D Prigge, Erin D Bigler, P Thomas Fletcher, et al.
The Journal of Pediatrics
|
July 26, 2011
Factors affecting growth in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial
Richard V Williams, Victor Zak, Chitra Ravishankar, et al.
Journal of Clinical and Experimental Neuropsychology
|
August 30, 2013
Neuropsychological investigation of motor impairments in autism
Tyler C Duffield, Haley G Trontel, Erin D Bigler, et al.
Journal of Hepatology
|
November 1, 2019
Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Journal of Hepatology
|
June 10, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Plos One
|
May 30, 2013
A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection
David Gardiner, Jay Lalezari, Eric Lawitz, et al.
Open Heart
|
April 19, 2019
Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study
Jo Krogsgaard Simonsen, Emil Nielsen Holck, Didier Carrié, et al.
Cardiology in the Young
|
December 21, 2018
Cardiac Networks United: an integrated paediatric and congenital cardiovascular research and improvement network
Michael Gaies, Jeffrey Anderson, Alaina Kipps, et al.
Lancet (London, England)
|
April 25, 2017
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B El-Khoueiry, Bruno Sangro, Thomas Yau, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Human Molecular Genetics
|
December 3, 2003
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase
Joanna L Jankowsky, Daniel J Fadale, Jeffrey Anderson, et al.
Autism Research : Official Journal of the International Society for Autism Research
|
February 26, 2013
Longitudinal Heschl's gyrus growth during childhood and adolescence in typical development and autism
Molly D Prigge, Erin D Bigler, P Thomas Fletcher, et al.
The Journal of Pediatrics
|
July 26, 2011
Factors affecting growth in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial
Richard V Williams, Victor Zak, Chitra Ravishankar, et al.
Journal of Clinical and Experimental Neuropsychology
|
August 30, 2013
Neuropsychological investigation of motor impairments in autism
Tyler C Duffield, Haley G Trontel, Erin D Bigler, et al.
Journal of Hepatology
|
November 1, 2019
Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Journal of Hepatology
|
June 10, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Plos One
|
May 30, 2013
A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection
David Gardiner, Jay Lalezari, Eric Lawitz, et al.
Open Heart
|
April 19, 2019
Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study
Jo Krogsgaard Simonsen, Emil Nielsen Holck, Didier Carrié, et al.
Cardiology in the Young
|
December 21, 2018
Cardiac Networks United: an integrated paediatric and congenital cardiovascular research and improvement network
Michael Gaies, Jeffrey Anderson, Alaina Kipps, et al.
Lancet (London, England)
|
April 25, 2017
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B El-Khoueiry, Bruno Sangro, Thomas Yau, et al.
Page
of 9